Filtration Practices of mRNA-LNP Drug Products (PMCM RFI2025.001)

NIIMBL  is pleased to share this Request for Information (RFI) on filtration solutions for mRNA-LNP drug products.

The goal of this RFI is to gather insights and ideas regarding innovative approaches, current practices, and validation strategies for sterile filtration of lipid nanoparticle (LNP)-based products, including mRNA therapeutics.

Please review the full RFI document for more background information and requirements.

The submission deadline is October 1, 2025 (5 pm ET).

Key Dates

August 12, 2025 RFI Release
October 1, 2025 Submission Deadline
Contact [email protected] with questions.

Become a member

We offer a variety of membership options that give you the flexibility to choose your organization’s level of engagement based on technology interests and priorities.